Medindia
Medindia LOGIN REGISTER
Advertisement

ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference

Friday, March 14, 2008 General News
Advertisement
EXTON, Pa., March 13 ViroPharma Incorporated(Nasdaq: VPHM) today announced that Vincent Milano, chief financial officerand chief operating officer of ViroPharma, will present at the Cowen & Company28th Annual Health Care Conference at 1:40 P.M. ET on Tuesday, March 18, 2008.The conference is being held at the Boston Marriott Copley Place.
Advertisement

ViroPharma's presentation will be webcast live for investors throughwww.viropharma.com and available through April 1, 2008.

About ViroPharma Incorporated
Advertisement

ViroPharma Incorporated is a biopharmaceutical company dedicated to thedevelopment and commercialization of products that address serious diseasestreated by physician specialists and in hospital settings. ViroPharmacommercializes Vancocin(R), approved for oral administration for treatment ofantibiotic-associated pseudomembranous colitis caused by Clostridium difficileand enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information, please download the packageinsert at http://www.viropharma.com/Products.aspx). ViroPharma currentlyfocuses its drug development activities in viral diseases includingcytomegalovirus (CMV) and hepatitis C (HCV). For more information onViroPharma, visit the company's website at www.viropharma.com.

SOURCE ViroPharma Incorporated
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close